Drug Search Results
More Filters [+]

DW-1330

Alternative Names: dw-1330, dw1330, dw 1330
Latest Update: 2021-04-01
Latest Update Note: Clinical Trial Update

Product Description

DW1330 is associated with the mechanism of glycemic control and inflammation pathways

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Taiwan Resonant Waves Research
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for DW-1330

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

TRWRDM1604001

N/A

Completed

Type 2 Diabetes

2020-07-15

Recent News Events

Date

Type

Title